[EN] TRANSGLUTAMINASE 2 (TG2) INHIBITORS<br/>[FR] INHIBITEURS DE TRANSGLUTAMINASE 2 (TG2)
申请人:SITARI PHARMA INC
公开号:WO2020033784A1
公开(公告)日:2020-02-13
Described herein are compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (TG2). Also described herein are methods for using such TG2 inhibitors, alone or in combination with other compounds, for treating diseases or conditions that would benefit from TG2 inhibition.